References

Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development

10.3390/ph3072090 · 2010 · External reference

Overview of Therapeutic Drug Monitoring

10.3904/kjim.2009.24.1.1 · 2009 · External reference

Host Factors Affecting Antiepileptic Drug Delivery‐Pharmacokinetic Variability

10.1016/j.addr.2011.10.003 · 2012 · External reference

Antiepileptic Drug Treatment in Pregnancy: Changes in Drug Disposition and Their Clinical Implications

10.1111/epi.12109 · 2013 · External reference

Oral Contraceptives Induce Lamotrigine Metabolism: Evidence From a Double‐Blind, Placebo‐Controlled Trial

10.1111/j.1528-1167.2007.00997.x · 2007 · External reference

Clinical Utility of Therapeutic Drug Monitoring of Antiepileptic Drugs: Systematic Review

2020 · External reference

Pharmacological Aspects of Antiseizure Medications: From Basic Mechanisms to Clinical Considerations of Drug Interactions and Use of Therapeutic Drug Monitoring

10.1002/epd2.20069 · 2023 · External reference

Correlation of Levetiracetam Concentration in Peripheral Blood Mononuclear Cells With Clinical Efficacy: A Sensitive Monitoring Biomarker in Patients With Epilepsy

10.1016/j.seizure.2020.03.009 · 2020 · External reference

Therapeutic Drug Monitoring of Lacosamide Among Children: Is It Helpful?

10.3389/fphar.2023.1164902 · 2023 · External reference

New Perspectives on ‘Breathomics’: Metabolomic Profiling of Non‐Volatile Organic Compounds in Exhaled Breath Using DI‐FT‐ICR‐MS

10.1038/s42003-024-05943-x · 2024 · External reference

Breath Analysis for Medical Diagnosis and Therapeutic Monitoring

2005 · External reference

Pharmacometabolomics via Real‐Time Breath Analysis Captures Metabotypes of Asthmatic Children Associated With Salbutamol Responsiveness

10.1016/j.isci.2024.111446 · 2024 · External reference

Acetazolamide: Old Drug, New Evidence?

10.1002/epi4.12619 · 2022 · External reference

Valproate Inhibits Mitochondrial Bioenergetics and Increases Glycolysis in Saccharomyces cerevisiae

10.1038/s41598-020-68725-5 · 2020 · External reference

Personalised Therapeutic Management of Epileptic Patients Guided by Pathway‐Driven Breath Metabolomics

10.1038/s43856-021-00021-3 · 2021 · External reference

Basal Ganglia Involvement in Temporal Lobe Epilepsy: A Functional and Morphologic Study

10.1212/01.wnl.0000297514.47695.48 · 2008 · External reference

NMR‐Based Metabolomics in Pediatric Drug Resistant Epilepsy – Preliminary Results

10.1038/s41598-019-51337-z · 2019 · External reference

Metabolomics as a Tool for the Characterization of Drug‐Resistant Epilepsy

10.3389/fneur.2017.00459 · 2017 · External reference

The Role of Dopamine Signaling in Epileptogenesis

10.3389/fncel.2013.00157 · 2013 · External reference

Monoamines and Their Metabolites in Cerebrospinal Fluid and Temporal Cortex of Epileptic Patients

10.1016/0920-1211(96)00030-7 · 1996 · External reference

Involvement of the Basal Ganglia in Refractory Epilepsy: An 18F‐Fluoro‐L‐DOPA PET Study Using 2 Methods of Analysis

2005 · External reference

Monoamine Metabolites in the CSF of Epileptic Patients

10.1212/wnl.29.8.1157 · 1979 · External reference

Secondary Neurotransmitter Deficiencies in Epilepsy Caused by Voltage‐Gated Sodium Channelopathies: A Potential Treatment Target?

10.1016/j.ymgme.2015.11.008 · 2016 · External reference

RNA‐Seq Analysis of Hippocampal Tissues Reveals Novel Candidate Genes for Drug Refractory Epilepsy in Patients With MTLE‐HS

10.1016/j.ygeno.2016.04.001 · 2016 · External reference

The Metabolic Basis of Epilepsy

10.1038/s41582-022-00651-8 · 2022 · External reference

The Effect of Antiepileptic Drugs on Mitochondrial Activity: A Pilot Study

10.1177/0883073809352888 · 2010 · External reference

Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof

10.3389/fncel.2018.00274 · 2018 · External reference

Mitochondria and Oxidative Stress in Epilepsy: Advances in Antioxidant Therapy

2025 · External reference

Effects of Antiepileptic Drugs on Mitochondrial Functions, Morphology, Kinetics, Biogenesis, and Survival

10.1016/j.eplepsyres.2017.07.003 · 2017 · External reference

Metabolic Concerns Associated With Antiepileptic Medications

2004 · External reference

Carnitine in the Treatment of Valproic Acid‐Induced Toxicity

10.1080/15563650902752376 · 2009 · External reference

Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations

10.9758/cpn.2020.18.4.507 · 2020 · External reference

Branched‐Chain Amino Acids and Brain Metabolism

10.1007/s11064-017-2261-5 · 2017 · External reference

Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments

10.3389/fpsyt.2019.00561 · 2019 · External reference

Insights From Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation

10.1007/s12035-021-02304-1 · 2021 · External reference

The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment

10.3389/fpsyt.2021.546801 · 2021 · External reference

GABA and Glutamate in the Human Brain

10.1177/1073858402238515 · 2002 · External reference

Aerobic Glycolysis in the Human Brain Is Associated With Development and Neotenous Gene Expression

10.1016/j.cmet.2013.11.020 · 2014 · External reference

Identification of Gene Regulatory Networks Affected Across Drug‐Resistant Epilepsies

10.1038/s41467-024-46592-2 · 2024 · External reference

Taking Your Breath Away: Metabolomics Breathes Life in to Personalized Medicine

10.1016/j.tibtech.2014.08.003 · 2014 · External reference

The Potential of Metabolomics in Biomedical Applications

10.3390/metabo12020194 · 2022 · External reference

The Human Volatilome: Volatile Organic Compounds (VOCs) in Exhaled Breath, Skin Emanations, Urine, Feces and Saliva

10.1088/1752-7155/8/3/034001 · 2014 · External reference